5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)

oleh: M. Callaghan, K.I. Ataga, L. De Franceschi, C. Minniti, N. Balachandran, D.-.C. Imbs, T. Perretti, J. Ramos, A. Sostelly, P. Bartolucci